Holen Sie sich die Stockscreener-App
121.03
0.71%
-0.87
Handel nachbörslich:
121.03
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt A?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$121.90
Offen:
$122.59
24-Stunden-Volumen:
1.93M
Relative Volume:
1.19
Marktkapitalisierung:
$34.51B
Einnahmen:
$6.53B
Nettoeinkommen (Verlust:
$1.26B
KGV:
27.82
EPS:
4.35
Netto-Cashflow:
$1.31B
1W Leistung:
-1.65%
1M Leistung:
-14.62%
6M Leistung:
-12.74%
1J Leistung:
-17.83%
1-Tages-Spanne:
$119.30
$123.28
1-Wochen-Bereich:
$119.30
$129.50
52-Wochen-Spanne:
$119.30
$155.35
Agilent Technologies Inc Stock (A) Company Profile
Firmenname
Agilent Technologies Inc
Sektor
Branche
Telefon
(408) 345-8886
Adresse
5301 STEVENS CREEK BLVD, SANTA CLARA, CA
Vergleichen Sie A mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
A
Agilent Technologies Inc
|
121.03 | 34.51B | 6.53B | 1.26B | 1.31B | 4.35 |
|
TMO
Thermo Fisher Scientific Inc
|
514.20 | 193.99B | 42.88B | 6.34B | 7.27B | 16.53 |
|
DHR
Danaher Corp
|
205.61 | 146.95B | 23.88B | 3.90B | 5.30B | 5.28 |
|
IDXX
Idexx Laboratories Inc
|
426.69 | 34.70B | 3.90B | 887.87M | 798.08M | 10.67 |
|
IQV
Iqvia Holdings Inc
|
183.48 | 32.35B | 15.41B | 1.37B | 2.11B | 7.50 |
Agilent Technologies Inc Stock (A) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-02-10 | Hochstufung | Barclays | Underweight → Equal Weight |
| 2024-08-28 | Eingeleitet | Wells Fargo | Overweight |
| 2024-07-10 | Hochstufung | Citigroup | Neutral → Buy |
| 2024-06-27 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2024-06-03 | Fortgesetzt | Jefferies | Hold |
| 2024-04-05 | Hochstufung | Stifel | Hold → Buy |
| 2023-12-13 | Eingeleitet | Wolfe Research | Outperform |
| 2023-12-12 | Herabstufung | BofA Securities | Buy → Neutral |
| 2023-11-17 | Herabstufung | UBS | Buy → Neutral |
| 2023-09-28 | Eingeleitet | Bernstein | Mkt Perform |
| 2023-07-31 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2023-05-24 | Bestätigt | Barclays | Equal Weight |
| 2023-05-24 | Bestätigt | BofA Securities | Buy |
| 2023-05-24 | Bestätigt | Citigroup | Neutral |
| 2023-05-24 | Bestätigt | Credit Suisse | Outperform |
| 2023-05-24 | Bestätigt | Evercore ISI | Outperform |
| 2023-05-24 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2023-05-24 | Bestätigt | Robert W. Baird | Outperform |
| 2023-05-24 | Bestätigt | SVB Securities | Outperform |
| 2023-05-24 | Bestätigt | Stifel | Hold |
| 2023-05-24 | Bestätigt | TD Cowen | Outperform |
| 2023-05-24 | Bestätigt | Wells Fargo | Overweight |
| 2023-05-11 | Eingeleitet | Barclays | Equal Weight |
| 2023-01-10 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2022-08-25 | Eingeleitet | Credit Suisse | Outperform |
| 2022-07-20 | Eingeleitet | UBS | Buy |
| 2022-07-08 | Herabstufung | Citigroup | Buy → Neutral |
| 2022-04-25 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2022-02-23 | Bestätigt | BofA Securities | Buy |
| 2022-02-23 | Bestätigt | Citigroup | Buy |
| 2022-02-23 | Bestätigt | Cowen | Outperform |
| 2022-02-23 | Bestätigt | Evercore ISI | Outperform |
| 2022-02-23 | Bestätigt | Stifel | Hold |
| 2022-02-23 | Bestätigt | Wells Fargo | Overweight |
| 2021-11-23 | Bestätigt | BofA Securities | Buy |
| 2021-11-23 | Bestätigt | Cowen | Outperform |
| 2021-11-23 | Bestätigt | Stifel | Hold |
| 2021-03-18 | Hochstufung | Citigroup | Neutral → Buy |
| 2021-02-17 | Hochstufung | BofA Securities | Neutral → Buy |
| 2020-12-02 | Eingeleitet | Goldman | Buy |
| 2020-11-25 | Hochstufung | UBS | Neutral → Buy |
| 2020-11-17 | Hochstufung | Cleveland Research | Neutral → Buy |
| 2020-11-10 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2020-09-30 | Eingeleitet | Atlantic Equities | Neutral |
| 2020-08-19 | Bestätigt | BofA Securities | Neutral |
| 2020-08-19 | Bestätigt | Citigroup | Neutral |
| 2020-08-19 | Bestätigt | Jefferies | Buy |
| 2020-08-19 | Bestätigt | Robert W. Baird | Outperform |
| 2020-08-19 | Bestätigt | SVB Leerink | Outperform |
| 2020-08-19 | Bestätigt | Stifel | Hold |
| 2020-08-19 | Bestätigt | Wells Fargo | Overweight |
| 2020-02-24 | Herabstufung | Needham | Buy → Hold |
| 2020-01-08 | Eingeleitet | Wells Fargo | Overweight |
| 2020-01-07 | Eingeleitet | Citigroup | Neutral |
| 2019-11-26 | Bestätigt | Needham | Buy |
| 2019-11-15 | Eingeleitet | Stifel | Hold |
| 2019-10-18 | Herabstufung | UBS | Buy → Neutral |
| 2019-07-16 | Herabstufung | BofA/Merrill | Buy → Neutral |
| 2019-07-15 | Herabstufung | Barclays | Overweight → Equal Weight |
Alle ansehen
Agilent Technologies Inc Aktie (A) Neueste Nachrichten
Breast Cancer Diagnostics Market Set for 6.9% CAGR Growth, projected to Hit USD 12.45 Billion by 2035 - GlobeNewswire Inc.
Agilent Technologies, Inc. (NYSE:A) Shares Bought by Zurcher Kantonalbank Zurich Cantonalbank - MarketBeat
Amundi Cuts Stock Position in Agilent Technologies, Inc. (NYSE:A) - MarketBeat
Agilent Technologies, Inc. (NYSE:A) Shares Acquired by PNC Financial Services Group Inc. - MarketBeat
Agilent Technologies, Inc. (NYSE:A) Shares Acquired by Steward Partners Investment Advisory LLC - Defense World
Bank Julius Baer & Co. Ltd Zurich Cuts Stock Holdings in Agilent Technologies, Inc. (NYSE:A) - MarketBeat
High-Performance Liquid Chromatography Market Top Players - openPR
Agilent’s PD-L1 IHC 28-8 pharmDx gets added indications under EU IVDR1 for NSLC - TipRanks
Andra AP fonden Sells 4,200 Shares of Agilent Technologies, Inc. (NYSE:A) - MarketBeat
Agilent PD-L1 IHC 28-8 pharmDx Receives EU IVDR Certification as a Companion Diagnostic Test for Non-small Cell Lung Cancer and Melanoma Indications - 01Net
Agilent's Cancer Diagnostic Kit Receives EU Approval for Two New Indications -March 10, 2025 at 10:21 am EDT - Marketscreener.com
Cytokine Market Projected To Witness Substantial Growth, 2025-2032:Abbott, AB Sciex, Agilent Technologies, - EIN News
Protein Engineering Market Projected To Witness Substantial Growth, 2025-2032: Agilent Technologies Inc., - EIN News
Agilent’s cancer diagnostic kit gains EU approval for new uses By Investing.com - Investing.com South Africa
LGT Capital Partners LTD. Sells 76,620 Shares of Agilent Technologies, Inc. (NYSE:A) - MarketBeat
AlphaQuest LLC Purchases 3,933 Shares of Agilent Technologies, Inc. (NYSE:A) - MarketBeat
Global IR Spectroscopy Market Deep Research 2025-2032 | Agilent Technologies, Inc., Bruker Corporation - openPR
Candriam S.C.A. Sells 4,199 Shares of Agilent Technologies, Inc. (NYSE:A) - MarketBeat
State of Michigan Retirement System Sells 2,500 Shares of Agilent Technologies, Inc. (NYSE:A) - MarketBeat
Assetmark Inc. Boosts Holdings in Agilent Technologies, Inc. (NYSE:A) - MarketBeat
Agilent Technologies, Inc. (NYSE:A) Shares Bought by Charles Schwab Investment Management Inc. - MarketBeat
Callan Family Office LLC Purchases New Shares in Agilent Technologies, Inc. (NYSE:A) - MarketBeat
Aigen Investment Management LP Acquires New Position in Agilent Technologies, Inc. (NYSE:A) - MarketBeat
Fisher Asset Management LLC Makes New $665,000 Investment in Agilent Technologies, Inc. (NYSE:A) - MarketBeat
Victory Capital Management Inc. Has $289.55 Million Position in Agilent Technologies, Inc. (NYSE:A) - MarketBeat
Agilent Technologies (NYSE:A) Sets New 52-Week LowHere's Why - MarketBeat
Agilent Technologies Announces Cash Dividend of 12 Cents per Share - AOL
Agilent Technologies director sells $881,008 in stock By Investing.com - Investing.com Australia
Agilent Technologies director sells $881,008 in stock - Investing.com India
Agilent Argues Federal Circuit Should Revive Its CRISPR Patents - Bloomberg Law
Candriam S.C.A. Reduces Stake in Agilent Technologies, Inc. (NYSE:A) - MarketBeat
Lung Cancer Diagnostics Market Forecast Report and Competitive Analysis 2025-2033 Featuring llumina, Abbott, Thermo Fisher Scientific, QIAGEN, Roche, Sanofi, Agilent Technologies, bioMerieux - Yahoo Finance
Quintet Private Bank Europe S.A. Sells 42,245 Shares of Agilent Technologies, Inc. (NYSE:A) - MarketBeat
Modera Wealth Management LLC Buys 2,053 Shares of Agilent Technologies, Inc. (NYSE:A) - MarketBeat
Cantillon Capital Management LLC Increases Stock Position in Agilent Technologies, Inc. (NYSE:A) - MarketBeat
Goldman Sachs Cuts Earnings Growth Outlook, Sees Investors Move From 'Excitement' To 'Boredom' - Benzinga
Noesis Capital Mangement Corp Grows Stock Holdings in Agilent Technologies, Inc. (NYSE:A) - MarketBeat
Flputnam Investment Management Co. Lowers Stock Holdings in Agilent Technologies, Inc. (NYSE:A) - MarketBeat
Agilent Technologies Inc. stock outperforms competitors on strong trading day - MarketWatch
55,886 Shares in Agilent Technologies, Inc. (NYSE:A) Bought by SVB Wealth LLC - MarketBeat
Molecular Spectroscopy Market Growth and Future Scope 2025-2032 | Agilent Technologies Inc., Bruker Corporation - openPR
Proficio Capital Partners LLC Acquires Shares of 194,031 Agilent Technologies, Inc. (NYSE:A) - MarketBeat
Agilent Tech stock hits 52-week low at $124.07 amid market shifts By Investing.com - Investing.com South Africa
Agilent Tech stock hits 52-week low at $124.07 amid market shifts - Investing.com Australia
Finanzdaten der Agilent Technologies Inc-Aktie (A)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.24%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):